Dose-finding Study of Selective Serotonin Reuptake Inhibitors to Enhance Neuroplasticity
Status:
Withdrawn
Trial end date:
2021-02-09
Target enrollment:
Participant gender:
Summary
The brain is able to change throughout life in response to learning, or injury, or to adapt
to changes in the environment, which is known as neuroplasticity. Stroke survivors suffer
disabling chronic motor impairments that have proven challenging to improve. Increasing
neuroplasticity using selective serotonin reuptake inhibitors (SSRIs) is a promising approach
to promote motor recovery in patients with stroke.